BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38690653)

  • 21. Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice.
    Davisson RL; Ding Y; Stec DE; Catterall JF; Sigmund CD
    Physiol Genomics; 1999 Jul; 1(1):3-9. PubMed ID: 11015555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Training-Induced Reduction of Angiotensinogen in Autonomic Areas-The Main Effect of Exercise on Brain Renin-Angiotensin System in Hypertensive Rats.
    Chaar LJ; Alves TP; Batista Junior AM; Michelini LC
    PLoS One; 2015; 10(9):e0137395. PubMed ID: 26372108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of angiotensinogen expression in the proximal tubule by intracellular angiotensin II via AT1a/MAPK/NF-кB signaling pathways.
    Zhuo JL; Kobori H; Li XC; Satou R; Katsurada A; Navar LG
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1103-12. PubMed ID: 26864937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Converting enzyme inhibitors differentially affect expression of genes of the renin-angiotensin system.
    Keuneke C; Yacullo R; Sugiura M; Mall G; Metzger R; Ganten D
    Clin Exp Hypertens; 1995 Apr; 17(3):551-74. PubMed ID: 7613528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor-Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen-Targeting Small Interfering RNA.
    Ranasinghe P; Addison ML; Webb DJ
    J Am Heart Assoc; 2022 Oct; 11(20):e027694. PubMed ID: 36216481
    [No Abstract]   [Full Text] [Related]  

  • 26. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
    Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
    Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats.
    Makino N; Sugano M; Ohtsuka S; Sawada S; Hata T
    Cardiovasc Res; 1999 Dec; 44(3):543-8. PubMed ID: 10690286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four-week inhibition of the renin-angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks.
    Byars SG; Prestes PR; Suphapimol V; Takeuchi F; De Vries N; Maier MC; Melo M; Balding D; Samani N; Allen AM; Kato N; Wilkinson-Berka JL; Charchar F; Harrap SB
    Cardiovasc Res; 2024 May; 120(7):769-781. PubMed ID: 38501595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valsartan chronotherapy reverts the non-dipper pattern and improves blood pressure control through mediation of circadian rhythms of the renin-angiotensin system in spontaneous hypertension rats.
    Yang K; Wang Y; Ding Y; Cui H; Zhou D; Chen L; Ma Z; Wang W; Zhang W; Luan J
    Chronobiol Int; 2019 Aug; 36(8):1058-1071. PubMed ID: 31096810
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiotensin II Receptor-Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats.
    Seki T; Goto K; Kansui Y; Ohtsubo T; Matsumura K; Kitazono T
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased mRNA expression of cardiac renin-angiotensin system and collagen synthesis in spontaneously hypertensive rats.
    Sano H; Okamoto H; Kitabatake A; Iizuka K; Murakami T; Kawaguchi H
    Mol Cell Biochem; 1998 Jan; 178(1-2):51-8. PubMed ID: 9546581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the renin-angiotensin system by a low-salt diet does not augment intratubular angiotensinogen and angiotensin II in rats.
    Shao W; Seth DM; Prieto MC; Kobori H; Navar LG
    Am J Physiol Renal Physiol; 2013 Mar; 304(5):F505-14. PubMed ID: 23303412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats.
    Moniwa N; Varagic J; Ahmad S; VonCannon JL; Ferrario CM
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):15-29. PubMed ID: 22222314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood.
    Peng JF; Kimura B; Fregly MJ; Phillips MI
    Hypertension; 1998 Jun; 31(6):1317-23. PubMed ID: 9622148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes-induced increase of renal medullary hydrogen peroxide and urinary angiotensinogen is similar in normotensive and hypertensive rats.
    Patinha D; Afonso J; Sousa T; Morato M; Albino-Teixeira A
    Life Sci; 2014 Jul; 108(2):71-9. PubMed ID: 24862547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice.
    Yiannikouris F; Gupte M; Putnam K; Thatcher S; Charnigo R; Rateri DL; Daugherty A; Cassis LA
    Hypertension; 2012 Dec; 60(6):1524-30. PubMed ID: 23108647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension.
    Tang X; Mohuczy D; Zhang YC; Kimura B; Galli SM; Phillips MI
    Am J Physiol; 1999 Dec; 277(6):H2392-9. PubMed ID: 10600860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensinogen Exerts Effects Independent of Angiotensin II.
    Lu H; Wu C; Howatt DA; Balakrishnan A; Moorleghen JJ; Chen X; Zhao M; Graham MJ; Mullick AE; Crooke RM; Feldman DL; Cassis LA; Vander Kooi CW; Daugherty A
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):256-65. PubMed ID: 26681751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of GPE-AGT nanoparticle shRNA transfection system mediated RNAi on early atherosclerotic lesion.
    Lu P; Yuan L; Wang Y; Du Q; Sheng J
    Int J Clin Exp Pathol; 2012; 5(7):698-706. PubMed ID: 22977667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.